DermaZinc

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DermaZinc
Generic name: PYRITHIONE ZINC
Manufacturer: WynnPharm Inc
Product type: HUMAN OTC DRUG
SPL set ID: e72e54ba-03fe-6748-e053-2a95a90a196f
SPL ID: 4388139e-9bb0-4c9c-e063-6394a90a4deb
Version: 4
Effective date: 2025-11-14
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:25:27

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M032	openfda.application_number
brand name		DermaZinc	openfda.brand_name
generic name		PYRITHIONE ZINC	openfda.generic_name
manufacturer name		WynnPharm Inc	openfda.manufacturer_name
ndc	package	35324-001-04	openfda.package_ndc
ndc	product	35324-001	openfda.product_ndc
ndc11	package	35324000104	derived:openfda.package_ndc
rxcui		259549	openfda.rxcui
rxcui		1306177	openfda.rxcui
spl id		4388139e-9bb0-4c9c-e063-6394a90a4deb	id
spl set id		e72e54ba-03fe-6748-e053-2a95a90a196f	set_id
unii		R953O2RHZ5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings ■ For external use only. ■ Ask a doctor before use if you have a condition that covers a large area of the body. When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.